Psychedelic News

This has been a busy quarter for the psychedelic industry, particularly Lucy Scientific Discovery Inc. The company has announced three acquisitions in the past three months. These acquisitions create an interesting and unexpected pathway for the company. The NASDAQ-listed Lucy Scientific Discovery has greatly expanded its reach within the psychedelic, wellness, and cannabis industries this quarter. It can only mean one thing— the company has a broad vision of its future and intends to position itself to operate within a vast ecosystem. First and foremost, Lucy Scientific Discovery is a manufacturing company. The company was granted a Controlled Substances Dealer’s…

Post-traumatic stress Disorder (PTSD) is a debilitating mental health condition that affects millions of people worldwide. It affects 5% of the US population, and viable treatment options are lacking. MDMA-assisted therapy offers a new glimmer of hope for people suffering from the aftereffects of trauma. The Multidisciplinary Association for Psychedelic Studies PBC, or MAPS, has been pioneering the effort to get this treatment into the hands of the people who need it. Today marks a major milestone in making that happen.  The psychedelic industry has been biting its time, waiting for the MAPP2 Phase III readout. As the third quarter…

In November 2022, Lusaris Therapeutics made news for its $60 million Series A round. Since then, there has been a curious silence from the company. We recently came across a rumor that the company was shutting down. After a month of attempting to confirm this, we have come up empty-handed. That within itself is strange and unusual.  There has been no news from the company since it announced the completion of the Series A funding round nearly a year ago. Furthermore, there is something suspicious about the state of the company beyond its lack of news.  The psychedelic life sciences…

Legal psychedelics are closer than ever to becoming a reality in California. Senator Scott Weiner has been trying to push a psychedelic bill through the California legislature for several years now, and the end is now within sight.  Weiner’s initial bill was unsuccessful. However, his second try has now made it to the governor’s desk. Senate Bill 58 has been slowly weaving its way through the legislative process for the past few months. This week, it made it through the last few steps before going to California’s governor, Gavin Newsom. The amended bill was approved by the California Assembly on…

Many experts have been predicting some big mergers and acquisitions in the psychedelic industry. Well, it looks like they were spot on.  This week has brought with it announcements of the two biggest acquisitions in the history of this emerging industry. On Monday, Cybin announced that it would be acquiring Small Pharma. Both are clinical-stage biotech companies with a focus on novel psychedelic drugs. The news of this acquisition was major but was quickly overshadowed by even bigger news. Just a few days later, the industry’s first big pharma acquisition was announced. Otsuka Pharmaceuticals plans to further its interests in…